Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity

Date
2015
Author
Ekici, Baris
Akdogan, Basri
Kir, Nur
Aydinoglu-Candan, Ozlem
Demirel, Atalay
Ozmen, Meral
ARAZ-ERSAN, Bilge
Yildiz-Inec, Dilbade
Tuncer, Samuray
Metadata
Show full item record
Abstract
Purpose: To evaluate the two-year follow-up of patients with type 1 retinopathy of prematurity (ROP) who received intravitreal bevacizumab (IVB) as adjunctive treatment.
URI
http://hdl.handle.net/20.500.12627/57272
https://doi.org/10.3109/02713683.2014.941070
Collections